drugset / Trial / NCT00456482

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant

NCT00456482

Phase 2/3 Terminated 239 enrolled Bausch & Lomb Incorporated
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a multi-center, randomized, double-masked, controlled study to evaluate the safety and efficacy of fluocinolone acetonide intravitreal implants for the management of subjects with non-infectious uveitis affecting the posterior segment of the eye. An additional objective is to compare the safety and efficacy of two doses of fluocinolone acetonide.

Timeline

Start
2002-05
Primary completion
2006-04
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject fluocinolone acetonide Small molecule 0.59 mg Intravitreal
Subject fluocinolone acetonide Small molecule 2.1 mg Intravitreal

Indications